Skip to main content
Livermore
Livermore
ZHEN

Syntax Research, Inc.

SEC CIK
0001999827
Latest filing
Jul 31, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Syntax Research, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
245
Value
$152.8K
% of portfolio
0.1%
Quarters held
12
Since Q3 2023
Holdings of REGN by Syntax Research, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026245$152.8K0.1%00.0%UnchangedHolders
Q1 2026245$189.3K0.1%00.0%UnchangedHolders
Q4 2025245$189.1K0.1%00.0%UnchangedHolders
Q3 2025245$137.8K0.1%00.0%UnchangedHolders
Q2 2025245$128.6K0.1%00.0%UnchangedHolders
Q1 2025245$155.4K0.1%00.0%UnchangedHolders
Q4 2024245$174.5K0.1%00.0%UnchangedHolders
Q3 2024245$257.6K0.2%−100−29.0%ReducedHolders
Q2 2024345$362.6K0.3%00.0%UnchangedHolders
Q1 2024345$332.1K0.3%00.0%UnchangedHolders
Q4 2023345$303.0K0.3%00.0%UnchangedHolders
Q3 2023345$283.9K0.2%–No prior filingHolders